MedicinePsychology

Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.

P. Tran, S. Hamilton, A. Kuntz, J. Potvin, S. Andersen, C. Beasley, G. Tollefson

1997.10.1JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

DOI: 10.1097/00004714-199710000-00010

tlooto Summary

Olanzapine seemed to have a risk-versus-benefit advantage in the management of psychotic symptoms, and the differential preclinical profiles of these two drugs were also evident in a controlled, clinical investigation.

Abstract

Abstract is not available.

Citation format

TRAN, P., et al. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1997, 17 5: 407–18.